Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v8-EN | Version v4-EN | |
|---|---|---|
| Language | English | English |
| Date Updated | 2023-08-30 | 2023-03-07 |
| Drug Identification Number | 02130955 | 02130955 |
| Brand name | TYPHIM VI | TYPHIM VI |
| Common or Proper name | TYPHIM Vi | TYPHIM Vi |
| Company Name | SANOFI PASTEUR LIMITED | SANOFI PASTEUR LIMITED |
| Ingredients | SALMONELLA TYPHI VI CAPSULAR POLYSACCHARIDE VACCINE | SALMONELLA TYPHI VI CAPSULAR POLYSACCHARIDE VACCINE |
| Strength(s) | 25MCG | 25MCG |
| Dosage form(s) | SOLUTION | SOLUTION |
| Route of administration | INTRAMUSCULAR INTRAMUSCULAR | INTRAMUSCULAR INTRAMUSCULAR |
| Packaging size | 1 x 0.5 mL | 1 x 0.5 mL |
| ATC code | J07AP | J07AP |
| ATC description | BACTERIAL VACCINES | BACTERIAL VACCINES |
| Reason for shortage | Demand increase for the drug. | Demand increase for the drug. |
| Anticipated start date | 2023-03-10 | 2023-03-10 |
| Actual start date | 2023-03-06 | 2023-03-06 |
| Estimated end date | 2023-10-31 | 2023-10-31 |
| Actual end date | 2023-08-29 | |
| Shortage status | Resolved | Actual shortage |
| Tier 3 Status | No | No |
| Company comments | Shortage in private market due to an increase in demand in addition to delay caused by a temporary bottleneck in filling & packaging operations for the product. No supply impact to the public market. | Shortage in private market due to an increase in demand in addition to delay caused by a temporary bottleneck in filling & packaging operations for the product. No supply impact to the public market. |
| Health Canada comments |